Technomedica

Basic Information

Stock Code
6678
Industry
Electrical Machinery
Category Detail
Commercial & Industrial Machinery
Prefecture
Kanagawa Prefecture
Establishment Year
September 1987
Listing Year
September 2003
Official Website
http://www.technomedica.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Terumo, Showa Kasei, PHC Holdings, Rion, Nihon Kohden, Fukuda Denshi, MURO, Yagami, Japan M.D.M., Nakanishi, Olympus, CYBERDYNE, Kawabe

Overview

Technomedica is a medical device manufacturer founded in 1987, boasting high technological capabilities in blood collection tube preparation devices and inspection equipment, and demonstrating expertise in the business machinery and equipment industry.

Current Situation

Technomedica recorded net sales of approximately ¥9.3 billion and operating profit of approximately ¥1.5 billion in the fiscal year ending March 2019, maintaining a solid financial foundation. Its flagship products, such as blood collection tube preparation devices and blood gas analyzers, are widely adopted in medical settings, sustaining competitiveness in Japan's medical device industry. In recent years, it has expanded its product lineup with specimen testing devices and phlebotomy support systems to flexibly meet customer needs. The company focuses on R&D, introducing new technologies and manufacturing and selling consumables to drive revenue growth. Building on its domestic sales channels, it is promoting exports and overseas expansion. It actively develops environmentally friendly products and emphasizes quality control, contributing to improved reliability in the medical field. Looking ahead, it aims to enhance operational efficiency through digital technologies and automation equipment, planning mid- to long-term growth. It advances product development and customer service enhancements in response to market changes, differentiating itself from competitors. It continues investing in new technologies to strengthen its presence in the medical device sector.

Trivia

Interesting Facts

  • Specialized in medical automation equipment consistently since its founding
  • Pioneering medical device manufacturer headquartered in Yokohama, Kanagawa Prefecture
  • Numerous blood collection tube preparation devices in operation across Japanese medical sites
  • Maintains stable revenue as a dedicated medical testing device manufacturer
  • Early adopter of RFID-compatible devices, proactive in technological innovation
  • Contributes to reducing burdens on medical staff through phlebotomy support systems
  • Handles in-house consumables manufacturing for thorough quality control of entire products
  • Highly regarded in the industry for prudent management and technological prowess
  • Focuses on financial soundness and technological development even after listing
  • Established a niche specialization in the medical market, achieving differentiation from competitors
  • New headquarters building constructed in 1996, contributing to local economy
  • Representative Director and President Masatomo Jitsuyoshi has led long-term management
  • Specimen management systems contribute to improved traceability in medical institutions
  • Diverse models accommodate various needs of medical facilities
  • Expanding exports, recognized overseas for Japanese-quality medical devices

Hidden Connections

  • Some technologies for blood collection tube preparation devices were jointly developed with major domestic medical device manufacturers
  • Competes with peers while involved in formulating industry standard specifications
  • Strong partnerships with medical supply providers through consumables manufacturing
  • Partner IT companies handle support for system shipments to medical institutions
  • Collaborates with university research facilities in Kanagawa Prefecture for joint research
  • Family shareholders of the representative contribute to management stability and long-term vision
  • Actively participates in industry trade shows to disseminate technology
  • Collaborates with related companies to advance new medical device development

Future Outlook

Growth Drivers

  • Increasing demand for automation and efficiency in medical settings
  • Expansion of testing needs due to aging society
  • Development of next-generation medical devices leveraging digital technology
  • Growth trends in domestic and international medical device markets
  • Market opportunities from regulatory easing and changes in medical policies
  • Expectations for improved testing accuracy through AI technology
  • Rising evaluation of Japanese-made medical devices in overseas markets
  • Expanding needs for integration with medical collaboration systems
  • Increasing demand for energy-saving and environmentally friendly products
  • Growing importance of medical testing devices for novel infectious disease countermeasures
  • Demand for customized medicine and personalized treatment devices
  • Spread of cloud-based testing data management

Strategic Goals

  • Achieve 30% domestic market share in medical device automation market
  • Expand overseas sales ratio to over 20%
  • Increase ratio of AI/IoT-equipped products across all products to over 50%
  • Expand lineup of low-environmental-impact products
  • Raise R&D expense ratio to 10% of net sales
  • Achieve 40% penetration rate of specimen management systems in domestic medical institutions
  • Increase number of medical device-related patents
  • Expand acquisition of international standard certifications for quality assurance systems
  • Acquire sustainability certifications for medical devices
  • Nationwide expansion of regional medical support activities

Business Segments

Medical Device Manufacturing and Sales

Overview
Provides specimen processing devices and management systems essential for medical settings, supporting efficient and accurate testing operations.
Competitiveness
Advanced automation technology and product development tailored to medical site needs
Customers
  • Hospitals
  • Testing Centers
  • Medical Institutions
  • Research Institutions
  • Medical Device Distributors
  • Medical Supply Stores
  • Pharmaceutical Companies
  • University Hospitals
  • Clinical Laboratory Technicians
  • Public Health Centers
Products
  • Blood Collection Tube Preparation Devices
  • Blood Gas Analyzers
  • Urine Testing Devices
  • Erythrocyte Sedimentation Rate Measurement Devices
  • Specimen Management Systems
  • Phlebotomy Support Software
  • Consumables (Reagents, Tubes)
  • Optional Devices
  • Peripheral Devices for Testing Equipment
  • System Integration

Export Business

Overview
Focuses on exporting medical devices to overseas markets to support global expansion.
Competitiveness
Japanese-quality medical devices and product lineup tailored to local needs
Customers
  • Overseas Medical Institutions
  • Medical Device Trading Companies
  • Overseas Testing Labs
  • Import Agents
Products
  • Blood Collection Tube Preparation Devices
  • Testing and Analysis Devices
  • Specimen Management Systems

Competitive Advantage

Strengths

  • Advanced automated phlebotomy device technology
  • Product development aligned with medical site needs
  • Solid financial foundation
  • Diverse product lineup
  • Robust quality management system
  • Established position in the domestic market
  • Continuous R&D investment
  • Expertise in blood collection tube preparation devices
  • Rapid customer response capabilities
  • Provision of specimen management solutions
  • Expansion into export business
  • Development capabilities for advanced analysis devices
  • Long-term trust relationships with customers
  • Differentiation through technological innovation
  • Strong direct sales to medical institutions

Competitive Advantages

  • Superior efficiency in testing operations compared to competitors through automation technology
  • Market leadership in blood gas measurement and phlebotomy support systems
  • Customized products that meet detailed medical site requirements
  • Trusted brand backed by years of track record
  • Broad customer base due to adaptability to diverse medical settings
  • Diversified revenue base through overseas market development
  • Improved diagnostic reliability through high-precision products
  • Stable supply ensured by in-house consumables manufacturing
  • Traceability features in specimen management systems as a key strength
  • Rapid response to market needs through ongoing technological development
  • High compliance with medical device regulations
  • Comprehensive post-installation maintenance and support
  • Advancement of differentiation from competitors through new technology adoption
  • Reduced operational costs through standardization and automation
  • Ensured product stability through stringent quality control

Threats

  • Intensifying competition in the medical device market
  • Increased product certification costs due to stricter regulations
  • Competitive disadvantage from delays in new technology adoption
  • Export price fluctuation risks from currency exchange variations
  • Trends toward reduced capital investment in medical settings
  • Increase in new market entrants
  • Risks of technology patent imitation or infringement
  • Medical budget cuts due to economic downturns
  • Product recall risks and brand impact
  • Supply delays from supply chain disruptions
  • Risks of inability to keep pace with rapid technological changes
  • Political and economic instability in overseas markets

Innovations

2023: Development of New Model for Automated Blood Collection Tube Preparation Device

Overview
Launched a new device model with enhanced high-speed processing and RFID management functions.
Impact
Improved phlebotomy efficiency by 20%, contributing to market share expansion.

2022: Update to Specimen Management System TRIPS

Overview
Improved UI/UX and added cloud compatibility to enhance usability.
Impact
Achieved significant improvements in customer satisfaction and adoption rate.

2021: Launch of Urine Dispensing Device with Qualitative Function

Overview
Device that automates qualitative urine testing to improve inspection accuracy.
Impact
Contributes to shorter testing times and addressing labor shortages in medical facilities.

2024: Initiation of IoT-Compatible Blood Gas Analyzer Development

Overview
Implemented remote monitoring and data management functions for equipment to promote medical efficiency.
Impact
Expected to reduce future equipment management costs.

2020: In-House Consumables Quality Improvement Project

Overview
Enhanced material quality of reagents and tubes to improve measurement accuracy and safety.
Impact
Improved product evaluations and secured market trust.

Sustainability

  • Promotion of medical waste recycling
  • CO2 emissions reduction through energy-saving designs
  • Material selection to reduce environmental impact of products
  • Implementation of employee environmental education programs
  • Participation in environmental conservation activities with local communities
  • Procurement policy for sustainable medical materials
  • Fuel consumption reduction through logistics optimization
  • Waste reduction through product longevity
  • Promotion of simplified and reusable packaging
  • Adoption of environmentally friendly manufacturing processes